Liu, Fang
Zhang, Jing
Zhu, Yuan
Su, Lianjiu
Li, Yiming
He, Li
Yu, Li
Peng, Zhiyong
Funding for this research was provided by:
Wu Jieping Medical Foundation (HRJJ20171026)
Article History
Received: 3 March 2020
Accepted: 27 December 2020
First Online: 25 January 2021
Ethics approval and consent to participate
: This study follows the principles of the Helsinki Declaration 2013. The whole protocol and related documents (e.g., CRFs, informed consents, etc.) have been reviewed and approved by the Ethics Committee of Zhongnan Hospital of Wuhan University (Clinical Ethical Approval No. 2018010) and the Ethics Committee of Wuhan Central Hospital of Tongji Medical College, Huazhong University of Science and Technology (Hospital Ethical Approval No. 201904) respectively. Investigators will give the written informed consent and inform patients about the purpose, intervention, benefits, and possible risks of this trial. Only participants who signed the written informed consent will be screened for enrolment.
: This protocol and findings of the trial will be disseminated through peer-reviewed journals and scientific conferences.
: None declared.